Premium
QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID‐19: The need for pharmacogenetic insights
Author(s) -
LopezMedina Ana I.,
CamposStaffico Alessandra M.,
Luzum Jasmine A.
Publication year - 2020
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/jce.14722
Subject(s) - hydroxychloroquine , medicine , azithromycin , covid-19 , prolongation , pharmacogenetics , torsades de pointes , qt interval , intensive care medicine , cardiology , virology , genotype , disease , gene , infectious disease (medical specialty) , biology , antibiotics , biochemistry , chemistry , outbreak , microbiology and biotechnology